Regulatory Requirement for Pharmaceutical Marketing in USA, EU and GCC: A Comparison
Abstract
The Gulf Cooperation Council (GCC) pharmaceutical are known to be a semi-regulated market when compared with European Union (EU) and Unites States of America (USA) drug regulatory market. Product registration in GCC was challenging task in comparison to EU and USA due to lack of proper harmonised guidelines and diversity in registration procedure. The six GCC member states namely Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates have established a good regulatory guideline of their own, for drug marketing. Need for establishment of well-regulated guidelines is to ensure quality, safety and efficacy of drugs. The regulatory guidelines of EU and USA are standard for other regulatory agencies worldwide, and also to semi-regulated countries of GCC. This paper mainly focuses the various aspects of registration procedures, scope and time lines for the registration in USA, EU and GCC. A comparison between regulatory procedures of GCC with USA and EU countries will give us complete view on GCC countries being well regulated and emerging pharmaceutical market.
Keywords: United States Food and Drug Administration (USFDA), Gulf Cooperation Council (GCC), European Medicines Agency (EMA)
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)
1. ________________
2. _______________
_3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
